Anti-TNFα therapy may inadvertently promote a tumor-promoting microenvironment by reducing the synthesis of anti-tumorigenic cytokines and increasing the expression of pro-tumorigenic factors [33,34]. The gene discussed is TNF; the disease is neoplasm.